DarioHealth
DRIO
20 hedge funds and large institutions have $5.31M invested in DarioHealth in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
54% more funds holding
Funds holding: 13 → 20 (+7)
13% more capital invested
Capital invested by funds: $4.7M → $5.31M (+$611K)
0% more ownership
Funds ownership: 0.04% → 0.05% (+0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$358K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$330K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$179K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.5K |
| 5 |
S
SignatureFD
Atlanta,
Georgia
|
+$22.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.08K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$594 |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$297 |
DRIO Hedge Fund Activity: Q1 2019 in Review
20 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2019, worth a combined $5.31M — up 13% from $4.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DRIO positions and 0 closed out — a net gain of 7 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $358K. The largest seller was BlackRock, cutting an estimated $2.08K.
- 20 institutional investors held DarioHealth (DRIO) as of Q1 2019, up from 13 in Q4 2018.
- Funds reported $5.31M of DarioHealth stock for Q1 2019, up 13% quarter-over-quarter.
- 7 funds opened new DarioHealth positions in Q1 2019 and 0 closed out, a net change of +7 holders.
- The largest DarioHealth buyer in Q1 2019 was Goldman Sachs, an estimated $358K added.
- The largest DarioHealth seller in Q1 2019 was BlackRock, an estimated $2.08K sold.
Based on aggregated 13F filings for Q1 2019.